The heart was developed jointly by the China Academy of Launch Vehicle Technology (CALT) and the Teda International Cardiovascular Hospital in North China's Tianjin.

The artificial heart has been sent for testing and inspection after thorough experiments on animals, citing Li Hong, former director of CALT from the state-owned China Aerospace Science and Technology Corporation.

The artificial heart uses magnetic and fluid levitation from a rocket system, and the "aerospace heart" is expected to move to clinical trials during the 13th Five-Year Plan (2016-20), state-run Global Times reported.

"The magnetic and fluid levitation technology can reduce the friction in the device to increase the working efficiency and extend the life span of the power generator," the report quoted as saying Song Zhongping, a military expert and TV commentator.

This technology used can reduce damage to the blood and enable the blood pump to work longer.

"There is no self-made artificial heart approved for sale in China. For now, patients have to rely on heart transplants," Sun Hongtao, associate chief physician at the Fuwai Cardiovascular Hospital.

China Academy of Launch Vehicle Technology (CALT) and Teda International Cardiovascular Hospital

China